Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2011 / Cilt: 17 - Sayı: 2

Doğal ve cerrahi menopozun kardiyovasküler risk markerları folat ve vitamin B12 düzeylerine etkisi

The influence of natural and surgical menopause on cardiovascular risk markers folate and vitamin B12 levels

Pages
90–97
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: We did not find any significant difference in studied cardiovascular risk markers, folate and vitamin B12 levels in perimenopausal and postmenopausal women except low-density lipoprotein cholesterol levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: To investigate the influence of both natural and surgical menopause on serum concentrations of lipids, lipoprotein-a, C-reactive protein, homocysteine, folate and vitamin B12 levels.
📊
Key Findings & Data:STUDY DESIGN: The study included 126 healthy women: 20 perimenopausal, 62 natural menopausal, and 44 surgical menopausal women.
💡
Conclusion & Impact:CONCLUSION: We did not find any significant difference in studied cardiovascular risk markers, folate and vitamin B12 levels in perimenopausal and postmenopausal women except low-density lipoprotein cholesterol levels.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: To investigate the influence of both natural and surgical menopause on serum concentrations of lipids, lipoprotein-a, C-reactive protein, homocysteine, folate and vitamin B12 levels. STUDY DESIGN: The study included 126 healthy women: 20 perimenopausal, 62 natural menopausal, and 44 surgical menopausal women. The serum levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglyceride, lipoprotein-a, C-reactive protein, homocysteine, folate and vitamin B12 levels were measured, and comparisons were made between the groups. RESULTS: The plasma levels of total cholesterol, triglyceride, lipoprotein-a, homocysteine and folate were non-significantly higher in natural menopause group compared to perimenopause group. Also plasma total cholesterol, lipoprotein-a, homocysteine, vitamin B12 levels were higher and high-density lipoprotein cholesterol level was lower in surgical menopause group compared to perimenopause group, the difference was not significant. The plasma level of low-density lipoprotein cholesterol was significantly higher in natural menopausal women than perimenopausal women (p<0.05). Surgical menopausal women had higher but non-significant low-density lipoprotein cholesterol levels than perimenopausal women. There was a negative correlation between age and high-density lipoprotein cholesterol in natural menopause group, and there was a positive correlation between age and homocysteine in natural and surgical menopausal groups (p<0.05). CONCLUSION: We did not find any significant difference in studied cardiovascular risk markers, folate and vitamin B12 levels in perimenopausal and postmenopausal women except low-density lipoprotein cholesterol levels.

Özet

AMAÇ: Doğal ve cerrahi menopozun serum lipidleri, lipoprotein- a, C-reaktif protein, homosistein, folat ve vitamin B12 düzeyleri üzerine etkisini araştırmak. GEREÇ VE YÖNTEM: Çalışmaya 126 sağlıklı kadın dahil edildi. Kadınların 20’si perimenopoz, 62’si doğal menopoz ve 44’ü cerrahi menopozda idi. Total kolesterol düzeyleri, düşük dansiteli lipoprotein-kolesterol, yüksek dansiteli lipoprotein-kolesterol, trigliserid, lipoprotein-a, C-reaktif protein, homosistein, folat ve vitamin B12 düzeyleri ölçüldü ve gruplar arası karşılaştırmalar yapıldı. BULGULAR: Doğal menopoz grubu ile perimenopozal grup arasında, total kolesterol, trigliserid, lipoprotein-a, homosistein ve folat düzeyleri bakımından anlamlı bir fark saptanmadı. Ayrıca cerrahi menopoz grubunda total kolesterol, lipoproteina, homosistein, vitamin B12 düzeyleri perimenopozal gruba göre yüksek, yüksek dansiteli lipoprotein-kolesterol düzeyi ise düşük saptanmasına rağmen bu fark istatistiksel olarak anlamlı değildi. Düşük dansiteli lipoprotein-kolesterol düzeyi doğal menopozal kadınlarda, perimenopozal kadınlara göre anlamlı olarak daha yüksekti (p<0,05). Cerrahi menopozal grupta perimenopozal gruba göre düşük dansiteli lipoprotein-kolesterol düzeyleri daha yüksek saptanmasına rağmen bu fark istatistiksel olarak anlamlı değildi. Doğal menopozal grupta yüksek dansiteli lipoprotein-kolesterol ile yaş arasında negatif bir korelasyon vardı (p<0,05). Hem cerrahi hem de doğal menopoz grubunda homosistein ile yaş arasında pozitif bir korelasyon saptandı (p<0,05). SONUÇ: Perimenopozal ve postmenopozal kadınlarda düşük dan siteli lipoprotein-kolesterol düzeyleri dışında, incelenen kardiyovasküler risk markerları, folat ve B12 vitamini düzeyleri açısından anlamlı bir fark saptanmamıştır.

🔖

Cite This Article

KIRAN, H., CEMGİL, D. A., KIRAN, G., COŞKUN, A., YANCAR, S., TOK, A., EKERBİÇER, H. Ç. (2011). Doğal ve cerrahi menopozun kardiyovasküler risk markerları folat ve vitamin B12 düzeylerine etkisi. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 17 - Sayı: 2, 90–97. https://ajindex.com/articles/218368

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Eaker ED, Chesebro JH, Sacks FM. et al. Cardiovascular disease in women. Circulation 1993;88:1999-2009
  2. Cummings SR, Black DM, Rubin SM. Lifetime risk of hip Colles’, or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med 1989;149: 2445-8
  3. Gordon T, Kannel WB, Hjortland MC. et al. Menopause and coronary heart disease, the Framingham study. Ann Intern Med 1978;89:157-61
  4. Lobo RA. Surgical menopause and cardiovascular risks. Menopause 2007;14:562-66
  5. Miller NE, Thelle DS, Forde OH. et al. The Tromso heartstudy. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet 1977;1:965-8
  6. Gordon T, Castelli WP, Hjortland MC. et al. High density lipoprotein as a protective factor againist coronary heart disease. The Framingham study. Am J Med 1977;62:707-14. 7. de Aloysio D, Gambacciani M, Meschia M. et al. The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group. Atherosclerosis 1999;147:147-53
  7. Bush TL, Fried LP, Barrett-Connor E. Cholesterol, lipop - ro teins and coronary heart disease in women. Clin Chem 1988;34:60-70
  8. Shlipak MG, Simon JA, Vittinghoff E, et al. Estrogen and progestin, lipoprotein(a) and the risk of recurrent coronary heart disease events after menopause. JAMA 2000; 283:1845-52
  9. Graham IM, Daly LE, Refsum HM. et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277: 1775-81
  10. Marchesoni D, Driul L, Plaino L, et al. Menopause rather than estrogen modifies plasma homocysteine levels. Int J Gynaecol Obstet 2003;81:293-7
  11. Christodoulakos G, Panoulis C, Rizos D. et al. Homocysteine and folate levels in postmenopausal women. Maturitas 2001;39:161-7
  12. Andersson A, Brattstrom L, Israelsson B. et al. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992;22:79-87
  13. Bruschi F, Daguati R, Parazzini F. et al. Age, menopausal status and homocysteine levels in women around menopause. Eur J Obstet Gynecol Reprod Biol 2005; 120:195-7
  14. Eidelman RS, Lamas GA, Hennekens CH. Aspirin, postmenopausal hormones and C-reactive protein. Arch Intern Med 2002;162:480-1
  15. National American Menopause Society. Menopause Practice: A Clinician’s Guide. Available at: http:// www.menopause.org/edumaterials/cliniciansguide/cliniciansguide. htm. Accessed 17 December 2005
  16. Howard BV, Kuller